And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is exceedingly modest this time around. We plan to hang with Mrs. Pharmalot, catch up on our growing reading list, and hopefully mellow out. And what about you? Autumn is nearly here, so why not forage for a few apples or take a long drive to enjoy the great outdoors. You could tune out the world, such as it is, with a good book. Or make time for someone special. The possibilities are endless. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …
Senate Republicans are warning Speaker Nancy Pelosi that her much-anticipated drug pricing plan is dead and will not be considered in the Senate, Politico confides. Senate Majority Leader Mitch McConnell (R-Ky.) ruled out any action on the bill, which would call for Medicare to negotiate drug prices for a minimum of 25 medicines and target drugs that cost the American health system the most. Pelosi rolled out the plan on Thursday to intense opposition from the drug industry — and McConnell.
Meanwhile, President Trump broke with most Republicans on Capitol Hill on the issue of drug pricing, saying on Twitter that it was “great to see” House Speaker Nancy Pelosi introduce a bill that many GOP lawmakers derided earlier in the day as “socialist,” STAT tells us. In the tweet, Trump also reiterated his support for an existing, bipartisan drug pricing package currently before the Senate, and encouraged lawmakers to pursue a bipartisan solution.
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect